| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AFF1
|
AF4/FMR2 family, member 1
|
|
AFF3
|
AF4/FMR2 family, member 3
|
|
AFF4
|
AF4/FMR2 family, member 4
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANKS1B
|
ankyrin repeat and sterile alpha motif domain containing 1B
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
ARID3A
|
AT rich interactive domain 3A (BRIGHT-like)
|
|
ARID5B
|
AT rich interactive domain 5B (MRF1-like)
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ARRB1
|
arrestin, beta 1
|
|
ASNS
|
asparagine synthetase (glutamine-hydrolyzing)
|
|
ATF5
|
activating transcription factor 5
|
|
ATM
|
ATM serine/threonine kinase
|
|
AUTS2
|
autism susceptibility candidate 2
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
|
BAALC
|
brain and acute leukemia, cytoplasmic
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L14
|
BCL2-like 14 (apoptosis facilitator)
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BLACE
|
B-cell acute lymphoblastic leukemia expressed
|
|
BLID
|
BH3-like motif containing, cell death inducer
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BLNK
|
B-cell linker
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BTG1
|
B-cell translocation gene 1, anti-proliferative
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
CA12
|
carbonic anhydrase XII
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP8AP2
|
caspase 8 associated protein 2
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCAR1
|
cell division cycle and apoptosis regulator 1
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCNA2
|
cyclin A2
|
|
CCND1
|
cyclin D1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
|
CD14
|
CD14 molecule
|
|
CD19
|
CD19 molecule
|
|
CD1D
|
CD1d molecule
|
|
CD24
|
CD24 molecule
|
|
CD27
|
CD27 molecule
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD70
|
CD70 molecule
|
|
CD81
|
CD81 molecule
|
|
CD8A
|
CD8a molecule
|
|
CD9
|
CD9 molecule
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2B-AS1
|
CDKN2B antisense RNA 1
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CEP85L
|
centrosomal protein 85kDa-like
|
|
CHST4
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4
|
|
CLECL1
|
C-type lectin-like 1
|
|
CNOT3
|
CCR4-NOT transcription complex, subunit 3
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
CREBBP
|
CREB binding protein
|
|
CREBL2
|
cAMP responsive element binding protein-like 2
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
DBN1
|
drebrin 1
|
|
DCX
|
doublecortin
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked
|
|
DHFR
|
dihydrofolate reductase
|
|
DHX32
|
DEAH (Asp-Glu-Ala-His) box polypeptide 32
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DNTT
|
DNA nucleotidylexotransferase
|
|
DPH1
|
diphthamide biosynthesis 1
|
|
DUSP16
|
dual specificity phosphatase 16
|
|
EBF1
|
early B-cell factor 1
|
|
EED
|
embryonic ectoderm development
|
|
EFNA5
|
ephrin-A5
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
ENG
|
endoglin
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
EP300
|
E1A binding protein p300
|
|
EPHA3
|
EPH receptor A3
|
|
EPHB4
|
EPH receptor B4
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPOR
|
erythropoietin receptor
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV6
|
ets variant 6
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCRL1
|
Fc receptor-like 1
|
|
FCRL2
|
Fc receptor-like 2
|
|
FCRL4
|
Fc receptor-like 4
|
|
FCRL5
|
Fc receptor-like 5
|
|
FHOD3
|
formin homology 2 domain containing 3
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FOXP1
|
forkhead box P1
|
|
FOXP3
|
forkhead box P3
|
|
FPGS
|
folylpolyglutamate synthase
|
|
FTO
|
fat mass and obesity associated
|
|
FUS
|
FUS RNA binding protein
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA3
|
GATA binding protein 3
|
|
GFI1
|
growth factor independent 1 transcription repressor
|
|
GGH
|
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
|
|
GIF
|
gastric intrinsic factor (vitamin B synthesis)
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTO2
|
glutathione S-transferase omega 2
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HDAC4
|
histone deacetylase 4
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HES5
|
hes family bHLH transcription factor 5
|
|
HFE
|
hemochromatosis
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HLF
|
hepatic leukemia factor
|
|
HNRNPH1
|
heterogeneous nuclear ribonucleoprotein H1 (H)
|
|
HOXA11
|
homeobox A11
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA1L
|
heat shock 70kDa protein 1-like
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGH
|
immunoglobulin heavy locus
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IKZF2
|
IKAROS family zinc finger 2 (Helios)
|
|
IL10
|
interleukin 10
|
|
IL15
|
interleukin 15
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2
|
|
IRF4
|
interferon regulatory factor 4
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNK18
|
potassium channel, two pore domain subfamily K, member 18
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LAT2
|
linker for activation of T cells family, member 2
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LIF
|
leukemia inhibitory factor
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LIMS1
|
LIM and senescent cell antigen-like domains 1
|
|
LMO1
|
LIM domain only 1 (rhombotin 1)
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
ME2
|
malic enzyme 2, NAD(+)-dependent, mitochondrial
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR100
|
microRNA 100
|
|
MIR101-1
|
microRNA 101-1
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR125B2
|
microRNA 125b-2
|
|
MIR142
|
microRNA 142
|
|
MIR143
|
microRNA 143
|
|
MIR150
|
microRNA 150
|
|
MIR15A
|
microRNA 15a
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR182
|
microRNA 182
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR196B
|
microRNA 196b
|
|
MIR210
|
microRNA 210
|
|
MIR223
|
microRNA 223
|
|
MIR335
|
microRNA 335
|
|
MIR451A
|
microRNA 451a
|
|
MIR499A
|
microRNA 499a
|
|
MIR502
|
microRNA 502
|
|
MIR612
|
microRNA 612
|
|
MIR9-1
|
microRNA 9-1
|
|
MIR9-2
|
microRNA 9-2
|
|
MIR9-3
|
microRNA 9-3
|
|
MIR99A
|
microRNA 99a
|
|
MIRLET7B
|
microRNA let-7b
|
|
MLLT1
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1
|
|
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
|
MLXIP
|
MLX interacting protein
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MNX1
|
motor neuron and pancreas homeobox 1
|
|
MPO
|
myeloperoxidase
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSI2
|
musashi RNA-binding protein 2
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTHFD1
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MUTYH
|
mutY homolog
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX2-2
|
NK2 homeobox 2
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NNMT
|
nicotinamide N-methyltransferase
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRXN1
|
neurexin 1
|
|
NSRP1
|
nuclear speckle splicing regulatory protein 1
|
|
NT5C2
|
5'-nucleotidase, cytosolic II
|
|
NUP214
|
nucleoporin 214kDa
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
P2RY8
|
purinergic receptor P2Y, G-protein coupled, 8
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PAX2
|
paired box 2
|
|
PAX4
|
paired box 4
|
|
PAX5
|
paired box 5
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PCDH10
|
protocadherin 10
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PGF
|
placental growth factor
|
|
PHB
|
prohibitin
|
|
PHF6
|
PHD finger protein 6
|
|
PIM2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
|
PIP4K2A
|
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLK1
|
polo-like kinase 1
|
|
PPP2R5A
|
protein phosphatase 2, regulatory subunit B', alpha
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRDM9
|
PR domain containing 9
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRL
|
prolactin
|
|
PROM1
|
prominin 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTK7
|
protein tyrosine kinase 7 (inactive)
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PVR
|
poliovirus receptor
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
RAD51
|
RAD51 recombinase
|
|
RAG1
|
recombination activating gene 1
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RASSF4
|
Ras association (RalGDS/AF-6) domain family member 4
|
|
RB1
|
retinoblastoma 1
|
|
RCSD1
|
RCSD domain containing 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RFC1
|
replication factor C (activator 1) 1, 145kDa
|
|
RHOU
|
ras homolog family member U
|
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
|
RPL10
|
ribosomal protein L10
|
|
RPL5
|
ribosomal protein L5
|
|
RUNX1
|
runt-related transcription factor 1
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SET
|
SET nuclear proto-oncogene
|
|
SETD8
|
SET domain containing (lysine methyltransferase) 8
|
|
SH2B3
|
SH2B adaptor protein 3
|
|
SHH
|
sonic hedgehog
|
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble)
|
|
SIAE
|
sialic acid acetylesterase
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC39A6
|
solute carrier family 39 (zinc transporter), member 6
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLX4IP
|
SLX4 interacting protein
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMYD2
|
SET and MYND domain containing 2
|
|
SOAT1
|
sterol O-acyltransferase 1
|
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
SP1
|
Sp1 transcription factor
|
|
SPRED1
|
sprouty-related, EVH1 domain containing 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
TACR1
|
tachykinin receptor 1
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TARDBP
|
TAR DNA binding protein
|
|
TAX1BP1
|
Tax1 (human T-cell leukemia virus type I) binding protein 1
|
|
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1
|
|
TCF3
|
transcription factor 3
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TERC
|
telomerase RNA component
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THAP1
|
THAP domain containing, apoptosis associated protein 1
|
|
TLR6
|
toll-like receptor 6
|
|
TLR9
|
toll-like receptor 9
|
|
TLX1
|
T-cell leukemia homeobox 1
|
|
TLX3
|
T-cell leukemia homeobox 3
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TRA
|
T cell receptor alpha locus
|
|
TRD
|
T cell receptor delta locus
|
|
TRDMT1
|
tRNA aspartic acid methyltransferase 1
|
|
TRG
|
T cell receptor gamma locus
|
|
TRIB2
|
tribbles pseudokinase 2
|
|
TSGA10
|
testis specific, 10
|
|
TTC12
|
tetratricopeptide repeat domain 12
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
TYK2
|
tyrosine kinase 2
|
|
TYMS
|
thymidylate synthetase
|
|
UBE2Q2
|
ubiquitin-conjugating enzyme E2Q family member 2
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UHMK1
|
U2AF homology motif (UHM) kinase 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WT1
|
Wilms tumor 1
|
|
XBP1
|
X-box binding protein 1
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZFX
|
zinc finger protein, X-linked
|
|
ZMIZ1
|
zinc finger, MIZ-type containing 1
|
|
ZNF296
|
zinc finger protein 296
|
|
ZNF423
|
zinc finger protein 423
|
